DE69815544D1 - Herstellung und verwendung von ortho-sulfonamido bicyclische heteroaryl hydroxamsäure derivate als matrix-metalloproteinase und tace inhibitoren - Google Patents
Herstellung und verwendung von ortho-sulfonamido bicyclische heteroaryl hydroxamsäure derivate als matrix-metalloproteinase und tace inhibitorenInfo
- Publication number
- DE69815544D1 DE69815544D1 DE69815544T DE69815544T DE69815544D1 DE 69815544 D1 DE69815544 D1 DE 69815544D1 DE 69815544 T DE69815544 T DE 69815544T DE 69815544 T DE69815544 T DE 69815544T DE 69815544 D1 DE69815544 D1 DE 69815544D1
- Authority
- DE
- Germany
- Prior art keywords
- carbon atoms
- heteroaryl
- ring
- phenyl
- carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55856 | 1993-04-30 | ||
US94418897A | 1997-10-06 | 1997-10-06 | |
US944188 | 1997-10-06 | ||
US5585698A | 1998-04-06 | 1998-04-06 | |
PCT/US1998/007380 WO1999018076A1 (en) | 1997-10-06 | 1998-04-14 | The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69815544D1 true DE69815544D1 (de) | 2003-07-17 |
DE69815544T2 DE69815544T2 (de) | 2004-05-13 |
Family
ID=26734697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69815544T Expired - Fee Related DE69815544T2 (de) | 1997-10-06 | 1998-04-14 | Herstellung und verwendung von ortho-sulfonamido bicyclische heteroaryl hydroxamsäure derivate als matrix-metalloproteinase und tace inhibitoren |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1021413B1 (de) |
JP (1) | JP2003520183A (de) |
KR (1) | KR20010030935A (de) |
CN (1) | CN1138760C (de) |
AT (1) | ATE242768T1 (de) |
AU (1) | AU760218B2 (de) |
BR (1) | BR9812727A (de) |
CA (1) | CA2303449A1 (de) |
DE (1) | DE69815544T2 (de) |
DK (1) | DK1021413T3 (de) |
ES (1) | ES2200335T3 (de) |
HU (1) | HUP0003880A3 (de) |
IL (1) | IL135105A0 (de) |
NO (1) | NO20001755L (de) |
NZ (1) | NZ503637A (de) |
PL (1) | PL339730A1 (de) |
PT (1) | PT1021413E (de) |
RU (1) | RU2202546C2 (de) |
WO (1) | WO1999018076A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR035478A1 (es) * | 1999-01-27 | 2004-06-02 | Wyeth Corp | Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene |
US6326516B1 (en) | 1999-01-27 | 2001-12-04 | American Cyanamid Company | Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors |
US20040235866A1 (en) * | 2001-09-05 | 2004-11-25 | Takahisa Hanada | Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
KR20040097375A (ko) | 2002-04-23 | 2004-11-17 | 시오노기 앤드 컴파니, 리미티드 | 피라졸로[1, 5-에이]피리미딘 유도체 및 이를 함유한엔에이디(피)에이취 산화효소 저해제 |
US7098241B2 (en) | 2002-12-16 | 2006-08-29 | Hoffmann-La Roche Inc. | Thiophene hydroxamic acid derivatives |
NZ579645A (en) * | 2007-03-14 | 2012-01-12 | Ranbaxy Lab Ltd | Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
EP2170884A2 (de) * | 2007-06-25 | 2010-04-07 | Boehringer Ingelheim International GmbH | Chemische verbindungen |
US8513421B2 (en) | 2010-05-19 | 2013-08-20 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
AU2019352741A1 (en) | 2018-10-04 | 2021-05-06 | Assistance Publique-Hôpitaux De Paris (Aphp) | EGFR inhibitors for treating keratodermas |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131215C (zh) * | 1995-11-13 | 2003-12-17 | 赫彻斯特股份公司 | 环和杂环N-取代的α-亚氨基异羟肟酸和羧酸 |
FR2748026B1 (fr) * | 1996-04-26 | 1998-06-05 | Adir | Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU743901B2 (en) * | 1996-10-16 | 2002-02-07 | Wyeth Holdings Corporation | Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors |
-
1998
- 1998-04-14 ES ES98915523T patent/ES2200335T3/es not_active Expired - Lifetime
- 1998-04-14 JP JP2000514888A patent/JP2003520183A/ja active Pending
- 1998-04-14 BR BR9812727-6A patent/BR9812727A/pt not_active Application Discontinuation
- 1998-04-14 KR KR1020007003657A patent/KR20010030935A/ko not_active Application Discontinuation
- 1998-04-14 AT AT98915523T patent/ATE242768T1/de not_active IP Right Cessation
- 1998-04-14 CN CNB988117630A patent/CN1138760C/zh not_active Expired - Fee Related
- 1998-04-14 HU HU0003880A patent/HUP0003880A3/hu unknown
- 1998-04-14 DE DE69815544T patent/DE69815544T2/de not_active Expired - Fee Related
- 1998-04-14 RU RU2000111469/04A patent/RU2202546C2/ru not_active IP Right Cessation
- 1998-04-14 PT PT98915523T patent/PT1021413E/pt unknown
- 1998-04-14 PL PL98339730A patent/PL339730A1/xx unknown
- 1998-04-14 AU AU69685/98A patent/AU760218B2/en not_active Ceased
- 1998-04-14 IL IL13510598A patent/IL135105A0/xx unknown
- 1998-04-14 CA CA002303449A patent/CA2303449A1/en not_active Abandoned
- 1998-04-14 DK DK98915523T patent/DK1021413T3/da active
- 1998-04-14 WO PCT/US1998/007380 patent/WO1999018076A1/en active IP Right Grant
- 1998-04-14 EP EP98915523A patent/EP1021413B1/de not_active Expired - Lifetime
- 1998-04-14 NZ NZ503637A patent/NZ503637A/xx unknown
-
2000
- 2000-04-05 NO NO20001755A patent/NO20001755L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CN1138760C (zh) | 2004-02-18 |
PL339730A1 (en) | 2001-01-02 |
EP1021413A1 (de) | 2000-07-26 |
CN1280568A (zh) | 2001-01-17 |
EP1021413B1 (de) | 2003-06-11 |
RU2202546C2 (ru) | 2003-04-20 |
CA2303449A1 (en) | 1999-04-15 |
ES2200335T3 (es) | 2004-03-01 |
NZ503637A (en) | 2002-10-25 |
NO20001755L (no) | 2000-05-31 |
DK1021413T3 (da) | 2003-10-06 |
KR20010030935A (ko) | 2001-04-16 |
ATE242768T1 (de) | 2003-06-15 |
PT1021413E (pt) | 2003-10-31 |
AU6968598A (en) | 1999-04-27 |
WO1999018076A1 (en) | 1999-04-15 |
AU760218B2 (en) | 2003-05-08 |
DE69815544T2 (de) | 2004-05-13 |
BR9812727A (pt) | 2000-08-22 |
IL135105A0 (en) | 2001-05-20 |
NO20001755D0 (no) | 2000-04-05 |
JP2003520183A (ja) | 2003-07-02 |
HUP0003880A2 (hu) | 2001-04-28 |
HUP0003880A3 (en) | 2001-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200001223A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200001224A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
NO2011026I2 (no) | Eribulin eller et farmasøytisk akseptabelt salt derav | |
EA200100553A1 (ru) | Замещенные бициклические производные, полезные в качестве противораковых агентов | |
EA199900494A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA199900756A1 (ru) | Замещенные изохинолины в качестве нервно-мышечных блокаторов ультракраткосрочного действия | |
EA200000871A1 (ru) | Ингибиторы фосфолипазных ферментов | |
FI850140L (fi) | Kemiska foereningar. | |
EA200100955A1 (ru) | 4-ОКСО-4,7-ДИГИДРОТИЕНО [2,3-b]ПИРИДИН-5-КАРБОКСАМИДЫ В КАЧЕСТВЕ АНТИВИРУСНЫХ СРЕДСТВ | |
DE69815544D1 (de) | Herstellung und verwendung von ortho-sulfonamido bicyclische heteroaryl hydroxamsäure derivate als matrix-metalloproteinase und tace inhibitoren | |
ATE25682T1 (de) | Indol-3-carboxamid-derivate. | |
ES493011A0 (es) | Procedimiento para la preparacion de derivados de pirimi- do-(6,1-a)-isoquinolein-4-onas | |
ES515081A0 (es) | "procedimiento para la preparacion de derivados de 6-metilprednisolona". | |
ATE251624T1 (de) | Granulatimide-derivate zur behandlung von krebs | |
SE7610038L (sv) | Miticida och aficida karboxylsyraestrar | |
EA200100297A1 (ru) | Моногидрат гидробромида элетриптана | |
EA199800527A1 (ru) | Производнфе 2-амино-5,6-дихлорбензимидазола, обладающие противовирусной активностью | |
ES2127862T3 (es) | Preparados cosmeticos que contienen 1-hidroxi-2-piridonas como agentes anticaspa y desodorantes. | |
DK0660822T3 (da) | Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler | |
ES506103A0 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas | |
OA07633A (fr) | Nouveaux dérivés du bicyclo (4.2.0.) octatrième-1,3,5 leur préparation et leur application en thérapeutique. | |
FI894068A0 (fi) | Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel. | |
CO4790110A1 (es) | Procedimiento para la purificacion de 4-amino-piperidinas estericamente inhibidas | |
DK428087A (da) | Dihydropyridin-5-phosphonsyre-cyclopropylenester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |